Researchers describe role of novel mutations in fosfomycin resistance

Researchers identified novel chromosomal mutations and described their role in the development of resistance of Escherichia coli (E. coli) to broad-spectrum antibiotic fosfomycin, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Researchers from France studied the genetic basis of fosfomycin resistance in a panel of E. coli isolates and found that certain […]

Continue reading »

Liquid nicotine used in e-cigarettes still a danger to children despite recent decline in exposures

A new study published online today by Pediatrics and conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital found that there were more than 8,200 calls to US poison centers regarding exposures to liquid nicotine and e-cigarettes among children younger than 6 years of age from January 2012 through April […]

Continue reading »

Seven-day antibiotic course delivers similar outcomes to 14-days for Gram-negative bacteraemia

A seven-day course of antibiotic treatment for Gram-negative bacteraemia (GNB), a serious infection that occurs when bacteria get into the bloodstream, was shown to offer similar patient outcomes as a 14-day course, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Researchers assessed several primary outcomes, including mortality and whether a patient was […]

Continue reading »

Targeted radiotherapy for breast cancer offers good quality of life and fewer side effects

Quality of life for women treated with a more targeted radiotherapy treatment – called accelerated partial breast irradiation – is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology. The treatment uses small tubes to deliver a higher dose […]

Continue reading »

New infection prevention tool improve transparency and standardization of practice

Researchers developed a new colour-coded visual tool called Infection Risk Scan, or IRIS, which is set to make it easier for healthcare workers to measure in which areas a hospital complies with guidelines and where it needs to implement measures to improve infection control and the use antimicrobial therapies, according to research presented at the 28th European Congress of Clinical […]

Continue reading »

West Nile virus reemerged and spread to new areas in Greece in 2017, researchers show

Madrid, Spain: West Nile virus (WNV), which is transmitted via mosquito bites, reemerged and spread to new territories of Greece in 2017 following a two-year hiatus in reported human cases, according to findings presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). During this reemergence, in the summer and early autumn of 2017, researchers diagnosed 45 […]

Continue reading »

Brachytherapy for cervical cancer does not increase the risk of ureteral stricture

A rare but potentially serious complication following radiation treatment for cervical cancer is a narrowing of the tube (the ureter) that takes urine from the kidneys to the bladder, which can lead to kidney damage and sometimes life-threatening infections. This is called ureteral stricture and, until now, there have been concerns that brachytherapy might increase the risk, although the treatment […]

Continue reading »

Measles serious threat for babies, toddlers, unvaccinated youths, ECDC says

The vast majority of measles cases in Europe were reported in unvaccinated patients, and children younger than two years old were at a higher risk of dying from measles than older patients, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Presenting author Dr Emmanuel Robesyn of the European Centre for Disease Prevention […]

Continue reading »

Lupus treatment generates positive results in Phase III clinical trial

New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis & Rheumatology findings are encouraging because lupus is among the leading causes of death in young women. SLE is […]

Continue reading »
1 368 369 370 371 372 388